Institut für Hygiene, Universitätsklinikum Witten-Herdecke, Campus Köln-Merheim.
Dtsch Arztebl Int. 2012 Jan;109(3):39-45. doi: 10.3238/arztebl.2012.0039. Epub 2012 Jan 20.
Infections with multidrug-resistant gram-negative bacteria are hard to treat and cause high morbidity and mortality. The direct transmission of such pathogens is well documented, and measures to protect other patients would seem indicated. Nonetheless, evidence-based recommendations are not yet available because of insufficient data from clinical trials.
An expert panel was convened by two sections of the German Society for Hygiene and Microbiology (the permanent committee on general and hospital hygiene and the special committee on infection prevention and antibiotic resistance in hospitals) to review existing data on the epidemiology and diagnostic evaluation of multidrug-resistant gram-negative pathogens. The panel carried out a selective review of the relevant literature, with special attention to national guidelines.
In this paper, the expert panel presents a definition of multidrug-resistant gram-negative pathogens and recommends measures for presenting the spread of infection from colonized and infected patients in non-outbreak situations. These measures depend on the risk profile of the clinical setting. They are mostly to be considered "expert opinion," rather than "evidence-based."
感染多重耐药革兰氏阴性菌难以治疗,导致高发病率和死亡率。这些病原体的直接传播已有充分记录,似乎有必要采取措施保护其他患者。然而,由于临床试验数据不足,目前还没有基于证据的建议。
德国卫生和微生物学学会的两个分会(常设委员会一般和医院卫生及特别委员会医院感染预防和抗生素耐药性)召集了一个专家小组,审查了关于多药耐药革兰氏阴性病原体的流行病学和诊断评估的现有数据。专家组对相关文献进行了选择性审查,特别关注国家指南。
在本文中,专家组提出了多药耐药革兰氏阴性病原体的定义,并建议采取措施在非暴发情况下报告定植和感染患者的感染传播情况。这些措施取决于临床环境的风险状况。它们大多被认为是“专家意见”,而不是“基于证据”。